Regentis Biomaterials Ltd (RGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 3,330 | 6,430 | 3,900 | 4,610 | 3,830 |
| TOTAL | $3,330 | $6,430 | $3,900 | $4,610 | $3,830 |
| Non-Current Assets | |||||
| Investments And Advances | 620 | 660 | 740 | 880 | 380 |
| Other Non-Current Assets | 6,030 | 6,530 | 6,310 | 6,150 | 5,900 |
| TOTAL | $6,650 | $7,190 | $7,050 | $7,030 | $6,280 |
| Total Assets | $9,980 | $13,620 | $10,950 | $11,640 | $10,110 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,910 | 3,960 | 2,340 | 2,290 | 2,260 |
| Accounts payable and accrued liabilities | 3,180 | 6,930 | 6,050 | 5,850 | 3,410 |
| Accrued Expenses | 2,360 | 0 | 0 | 0 | 1,920 |
| Other current liabilities | 320 | 490 | 460 | 450 | 460 |
| TOTAL | $11,770 | $11,380 | $8,850 | $8,590 | $8,050 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 22,030 | 20,770 | 20,730 | 20,710 | 20,580 |
| TOTAL | $27,290 | $27,080 | $27,180 | $27,290 | $27,290 |
| Total Liabilities | $39,060 | $38,460 | $36,030 | $35,880 | $35,340 |
| Shareholders' Equity | |||||
| Common Shares | 10,610 | 10,610 | 10,610 | 10,610 | 10,610 |
| TOTAL | $10,610 | $10,610 | $10,610 | $10,610 | $10,610 |
| Total Liabilities And Equity | $49,670 | $49,070 | $46,640 | $46,490 | $45,950 |